ARTICLE | Distillery Therapeutics
Cancer
February 28, 2017 11:55 PM UTC
Patient, cell culture and mouse studies suggest inhibiting IL-35 could help treat metastatic pancreatic ductal carcinoma (PDAC). In 123 PDAC patients, high levels of EBI3 and IL-12A in primary tumors ...